Physician profile
David Koelsch
NPI 1013919489
$931.41
in general payments reported to CMS, 2019-2025
19 companies · $15.02 in 2025
The $15.02 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $96.84 · 2021: $390 · 2022: $118 · 2025: $15.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $293.18 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $94.94 | 2021-2022 | |
| Abbvie INC. | $58.61 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $55.30 | 2019 | |
| Innocoll Pharmaceuticals Limited | $50.17 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.30 | 2020-2021 | |
| Smith+Nephew, INC. | $46.61 | 2019-2021 | |
| Tela Bio, INC. | $42.02 | 2021-2022 | |
| Tetraphase Pharmaceuticals, INC. | $40.18 | 2019-2020 | |
| Kci USA, INC. | $37.62 | 2020-2021 | |
| Genentech USA, INC. | $27.58 | 2019 | |
| Ekos Corporation | $23.66 | 2019 | |
| Karl Storz Endoscopy-America | $20.92 | 2021 | |
| Angiodynamics, INC. | $19.99 | 2022 | |
| Hartmann USA, INC. | $16.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.70 | 2019 | |
| Riggs Hospital Supplies, INC. | $15.02 | 2025 | |
| Medtronic Vascular, INC. | $12.39 | 2019 | |
| Avanos Medical | $11.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Koelsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.